Articles
EPR Academy, Part 2 of 6: The EPR Process – From Request to Reexamination Certificate
December 5, 2025
IP Updates
Federal Circuit IP Blog
Federal Circuit Affirms § 102(b) Invalidity; Source Code Commands Are Not Hearsay
May 14, 2026
Never miss an Insight.
Sign upArticles
Trending at the PTAB: Petitioners' Settled Expectations Trending at the PTAB: Petitioners' Settled Expectations
October 1, 2025
Law360Webinar
PTAB Developments, Including Discretionary Denials and Related Procedures PTAB Developments, Including Discretionary Denials and Related Procedures
July 24, 2025
Webinar
Webinar
Observations on One Year of IPR and PGR Institution Denials and Final Written Decisions: Life Sciences Observations on One Year of IPR and PGR Institution Denials and Final Written Decisions: Life Sciences
December 3, 2024
Webinar
Articles
Critical Things to Know About Director Review Practice at the USPTO Critical Things to Know About Director Review Practice at the USPTO
October 22, 2024
Intellectual Asset Management (IAM)Articles
Breeders’ Rights No Longer a Pipe Dream for New Marijuana Varieties? Breeders’ Rights No Longer a Pipe Dream for New Marijuana Varieties?
August 13, 2024
Cannabis Business ExecutiveWebinar
Section 102 and Prior Art: Navigating the Expanded Scope of Prior Art and AIA Exceptions Section 102 and Prior Art: Navigating the Expanded Scope of Prior Art and AIA Exceptions
August 7, 2024
Webinar
Prosecution First Blog
Filing of Plant Applications in USPTO’s Patent Center Appears to Have Taken Root Filing of Plant Applications in USPTO’s Patent Center Appears to Have Taken Root
June 7, 2024
Webinar
Recent Court Decisions in the Life Sciences Recent Court Decisions in the Life Sciences
May 22, 2024
Webinar
At the PTAB Blog
USPTO Publishes Notice of Proposed Rulemaking for Director Review USPTO Publishes Notice of Proposed Rulemaking for Director Review
April 16, 2024
Articles
Strategic Intellectual Property Considerations for Protecting AI Innovations in Life Sciences Strategic Intellectual Property Considerations for Protecting AI Innovations in Life Sciences
January 2023
International Pharmaceutical IndustryArticles
Key Insights from the PTAB’s Updated Orange Book and Biologic Patent Study Key Insights from the PTAB’s Updated Orange Book and Biologic Patent Study
August 30, 2021
IP WatchdogDue to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.